Publication / Source: www.neuro-central.com
Authors: Roisin Conneely, Future Science Group
Researchers from Northwestern University (IL, USA) have uncovered the anti-cancer properties of huntingtin, the gene that becomes mutated in Huntington’s disease (HD). The findings were recently published in EMBO Press.
Characteristically, patients with trinucleotide repeat disorders such as HD exhibit severe neurological pathologies but are also known to have reduced cancer susceptibility.
To view restricted content, please:
